-
M648820-1mg
Aladdin
MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan (C09-1152-799)
Price: $291.73List Price: $324.14MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan is a pharmaceutical composition containing antibody agent conjugate ( ADC ). (extracted from patent WO2021190581 Example 1-8)Form:SolidIC50&: Target:Auristatin. -
M648820-5mg
Aladdin
MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan (C09-1152-800)
Price: $817.08List Price: $907.87MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan is a pharmaceutical composition containing antibody agent conjugate ( ADC ). (extracted from patent WO2021190581 Example 1-8)Form:SolidIC50&: Target:Auristatin. -
M648881-1mg
Aladdin
MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan (C09-1152-818)
Price: $541.08List Price: $601.20MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan is a agent-linker conjugate for ADC , contains the ADC linker (MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic acid) and a DNA topoisomerase I inhibitor Exatecan ( HY-13631 ). -
M648881-5mg
Aladdin
MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan (C09-1152-819)
Price: $1,537.08List Price: $1,707.87MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan is a agent-linker conjugate for ADC , contains the ADC linker (MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic acid) and a DNA topoisomerase I inhibitor Exatecan ( HY-13631 ). -
M648597-10×1mgMc-MMAE is a protective group (maleimidocaproyl)-conjugated monomethyl auristatin E (MMAE), which is a potent tubulin inhibitor. Mc-MMAE is a agent-linker conjugate for ADC.In VitroSynthesis of maleimidocaproyl-MMAE (mc-MMAE) requires the addition
-
M648597-1mgMc-MMAE is a protective group (maleimidocaproyl)-conjugated monomethyl auristatin E (MMAE), which is a potent tubulin inhibitor. Mc-MMAE is a agent-linker conjugate for ADC.In VitroSynthesis of maleimidocaproyl-MMAE (mc-MMAE) requires the addition
-
M648597-5×1mgMc-MMAE is a protective group (maleimidocaproyl)-conjugated monomethyl auristatin E (MMAE), which is a potent tubulin inhibitor. Mc-MMAE is a agent-linker conjugate for ADC.In VitroSynthesis of maleimidocaproyl-MMAE (mc-MMAE) requires the addition
-
M649695-10mgMC-SN38 is a agent-linker conjugate composed of a potent microtubule-disrupting agent SN38 and a non-cleavable MC linker to make antibody agent conjugate (ADC). SN-38, an active metabolite of the Topoisomerase I inhibitor Irinotecan, inhibits DNA
-
M649695-25mgMC-SN38 is a agent-linker conjugate composed of a potent microtubule-disrupting agent SN38 and a non-cleavable MC linker to make antibody agent conjugate (ADC). SN-38, an active metabolite of the Topoisomerase I inhibitor Irinotecan, inhibits DNA
-
M649695-5mgMC-SN38 is a agent-linker conjugate composed of a potent microtubule-disrupting agent SN38 and a non-cleavable MC linker to make antibody agent conjugate (ADC). SN-38, an active metabolite of the Topoisomerase I inhibitor Irinotecan, inhibits DNA
-
M646361-100mgMC-VA-PAB-Exatecan is a agent-linker conjugate for ADC . MC-VA-PAB-Exatecan contains the ADC linker (peptide MC-VA-PAB) and a DNA topoisomerase I inhibitor Exatecan ( HY-13631 ). MC-VA-PAB-Exatecan synthesized ADC shows good antitumor
-
M646361-10mgMC-VA-PAB-Exatecan is a agent-linker conjugate for ADC . MC-VA-PAB-Exatecan contains the ADC linker (peptide MC-VA-PAB) and a DNA topoisomerase I inhibitor Exatecan ( HY-13631 ). MC-VA-PAB-Exatecan synthesized ADC shows good antitumor